PBM
Propel Bio Management Portfolio holdings
AUM
$82.4M
This Quarter Return
+11.81%
1 Year Return
+29.32%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$82.4M
AUM Growth
+$82.4M
(-4.3%)
Cap. Flow
-$7.45M
Cap. Flow
% of AUM
-9.04%
Top 10 Holdings %
Top 10 Hldgs %
97.53%
Holding
20
New
2
Increased
5
Reduced
2
Closed
4
Top Buys
| 1 |
Achieve Life Sciences
ACHV
|
$8.36M |
| 2 |
Abeona Therapeutics
ABEO
|
$1.99M |
| 3 |
Capricor Therapeutics
CAPR
|
$695K |
| 4 |
Milestone Pharmaceuticals
MIST
|
$660K |
| 5 |
Delcath Systems
DCTH
|
$659K |
Top Sells
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$9.95M |
| 2 |
Avidity Biosciences
RNA
|
$5.27M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$2.25M |
| 4 |
Phathom Pharmaceuticals
PHAT
|
$2.03M |
| 5 |
Compass Therapeutics
CMPX
|
$434K |
Sector Composition
| 1 | Healthcare | 69.43% |
| 2 | Energy | 30.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Plains GP Holdings
PAGP
$3.82B
| $24.7M | 30.01% |
1,272,360
| – | – |
|
|
2
Achieve Life Sciences
ACHV
$152M
| $13.9M | 16.88% |
6,153,091
+3,699,999
| +151% | +$8.36M |
|
3
Akero Therapeutics
AKRO
$3.74B
| $12.2M | 14.82% |
228,884
| – | – |
|
|
4
Phathom Pharmaceuticals
PHAT
$864M
| $8.85M | 10.74% |
922,927
-212,000
| -19% | -$2.03M |
|
|
5
Abeona Therapeutics
ABEO
$350M
| $5.53M | 6.71% |
974,022
+350,000
| +56% | +$1.99M |
|
6
Applied Therapeutics
APLT
$71M
| $3.51M | 4.26% |
11,285,420
| – | – |
|
|
7
Milestone Pharmaceuticals
MIST
$156M
| $3.48M | 4.22% |
1,791,557
+340,000
| +23% | +$660K |
|
|
8
Delcath Systems
DCTH
$385M
| $3.07M | 3.73% |
226,052
+48,452
| +27% | +$659K |
|
9
TScan Therapeutics
TCRX
$102M
| $3.03M | 3.67% |
2,087,139
| – | – |
|
10
Zevra Therapeutics
ZVRA
$509M
| $2.04M | 2.48% |
231,874
+52,000
| +29% | +$458K |
|
|
11
Capricor Therapeutics
CAPR
$287M
| $695K | 0.84% |
+70,000
| New | +$695K |
|
12
Athira Pharma
ATHA
$15.3M
| $451K | 0.55% |
1,492,792
| – | – |
|
|
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $423K | 0.51% |
146,381
| – | – |
|
|
14
Compass Therapeutics
CMPX
$483M
| – | – |
-228,317
| Closed | -$434K |
|
|
15
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – |
-30,032
| Closed | -$9.95M |
|
|
16
Avidity Biosciences
RNA
$5.99B
| – | – |
-178,500
| Closed | -$5.27M |
|
|
17
Syndax Pharmaceuticals
SNDX
$1.41B
| – | – |
-183,259
| Closed | -$2.25M |
|